- Ocrelizumab - pharmacoloical profile2018 | Faculty of Medicine in Pilsen
- 2020 AAN Highlights Long-term data on efficacy of CD20+depletion B-cells in the treatment of MS2020 | First Faculty of Medicine
- Musculoskeletal ultrasound in neurology2017 | First Faculty of Medicine
- Treatment targeted for B lymphocytes - significant progress in the treatment of multiple sclerosis2018 | Publication without faculty affiliation
- Long-term safety of ocrelizumab in the treatment of multiple sclerosis2020 | Faculty of Medicine in Pilsen
- Current role of evoked potentials in multiple sclerosis diagnostics and monitoring2021 | Third Faculty of Medicine
- Ocrelizumab in clinical trials2017 | First Faculty of Medicine